We are live on ! Find out more
RIG

Roosevelt Investment Group Portfolio holdings

AUM $1.39B
1-Year Est. Return 5.42%
This Fund
S&P 500
This Quarter Est. Return
+12.69%
1 Year Est. Return
-5.42%
3 Year Est. Return
+57.62%
5 Year Est. Return
+104.74%
10 Year Est. Return
AUM
$1.81B
AUM Growth
+$192M
Cap. Flow
+$12M
Cap. Flow %
0.67%
Top 10 Hldgs %
33.84%
Holding
304
New
57
Increased
125
Reduced
63
Closed
17

Sector Composition

Rank Sector Weight
1 Technology 19.48%
2 Financials 11.97%
3 Consumer Discretionary 11.94%
4 Industrials 9.08%
5 Healthcare 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XIFR
51
XPLR Infrastructure LP
XIFR
$1.08B
$7.21M 0.4%
85,371
+30
+0% +$2.51K
PFE icon
52
Pfizer
PFE
$153B
$6.08M 0.34%
102,892
+7,998
+8% +$396K
LMT icon
53
Lockheed Martin
LMT
$136B
$5.59M 0.31%
15,743
-1,512
-9% -$523K
PG icon
54
Procter & Gamble
PG
$339B
$5.54M 0.31%
33,857
+144
+0.4% +$21.4K
ABBV icon
55
AbbVie
ABBV
$435B
$5.54M 0.31%
40,877
+4,977
+14% +$588K
JNJ icon
56
Johnson & Johnson
JNJ
$625B
$5.53M 0.31%
32,352
-1,625
-5% -$266K
SPY icon
57
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$5.22M 0.29%
10,998
+4,536
+70% +$2.08M
AJG icon
58
Arthur J. Gallagher & Co
AJG
$63.6B
$4.95M 0.27%
29,183
VEA icon
59
Vanguard FTSE Developed Markets ETF
VEA
$236B
$4.89M 0.27%
95,822
+679
+0.7% +$34.9K
SPYM
60
State Street SPDR Portfolio S&P 500 ETF
SPYM
$168B
$4.84M 0.27%
86,747
-285,451
-77% -$15.4M
CVS icon
61
CVS Health
CVS
$122B
$4.78M 0.26%
46,373
+4,618
+11% +$427K
SPIB icon
62
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$4.61M 0.26%
127,538
+12,630
+11% +$458K
KKR icon
63
KKR & Co
KKR
$92.3B
$4.33M 0.24%
58,100
+10,000
+21% +$738K
WY icon
64
Weyerhaeuser
WY
$18.4B
$4.32M 0.24%
104,834
+8,320
+9% +$316K
AZN icon
65
AstraZeneca
AZN
$250B
$4.08M 0.23%
35,000
+5,000
+17% +$588K
ETN icon
66
Eaton
ETN
$174B
$3.94M 0.22%
22,769
+310
+1% +$51.4K
INTC icon
67
Intel
INTC
$513B
$3.91M 0.22%
75,918
+7,483
+11% +$383K
VB icon
68
Vanguard Morningstar Small-Cap ETF
VB
$82.4B
$3.85M 0.21%
+17,040
New +$3.87M
IBM icon
69
IBM
IBM
$224B
$3.73M 0.21%
27,909
+830
+3% +$104K
VZ icon
70
Verizon
VZ
$196B
$3.73M 0.21%
71,685
+11,442
+19% +$597K
AGGY icon
71
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$926M
$3.53M 0.2%
68,240
+8,969
+15% +$465K
GOOG icon
72
Alphabet (Google) Class C
GOOG
$4.32T
$3.52M 0.2%
24,360
-220
-0.9% -$31.8K
SO icon
73
Southern Company
SO
$107B
$3.52M 0.19%
51,321
+11,377
+28% +$725K
OUT icon
74
Outfront Media
OUT
$5.49B
$3.4M 0.19%
128,902
+11,176
+9% +$288K
META icon
75
Meta Platforms (Facebook)
META
$1.51T
$3.27M 0.18%
9,722
-49,605
-84% -$16.5M

Similar funds

Roosevelt Investment Group's Q4 2021 Portfolio in Review

As of Q4 2021, Roosevelt Investment Group held 304 positions worth $1.81B, up 12% from $1.61B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Roosevelt Investment Group's Q4 2021 filing shows 57 new, 125 increased, 63 reduced and 17 closed positions. Its largest new stake was Global Blood Therapeutics, Inc.: 416,665 shares worth $12.2M. The largest sale was Lamb Weston, an estimated $18.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Roosevelt Investment Group's largest Q4 2021 buy was Global Blood Therapeutics, Inc.: 416,665 shares worth $12.2M.
  • Roosevelt Investment Group added most to Vanguard S&P 500 ETF in Q4 2021, an estimated $14.5M increase.
  • Roosevelt Investment Group's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $16.5M.
  • Roosevelt Investment Group fully exited Lamb Weston in Q4 2021, selling an estimated $18.8M.
  • Roosevelt Investment Group's ten largest holdings make up 34% of its $1.81B portfolio in Q4 2021.
  • Roosevelt Investment Group opened 57 new positions and closed 17 in Q4 2021.
  • Roosevelt Investment Group's portfolio value rose 12% quarter-over-quarter to $1.81B.

Based on Roosevelt Investment Group's 13F filing for Q4 2021, filed 2 Feb 2022.